Effect Observation on Travenous Thrombolysis with Recombinant Tissue-type Plasminogen Activator on Treating Acute Cerebral Infarction
XU Zhen-hua
YAN Wei-jian
DENG Yu
Abstract：Objective:To investigate the effect of Recombinant Tissue-type Plasminogen Activator(rt-PA) thrombolytic therapy cerebral function and safety.Method:From January 2012 to June 2014 admitted to our hospital the incidence <3 h 44 patients with acute cerebral infarction were randomly divided into two groups,thrombolysis thrombolysis group received rt-PA thrombolytic therapy, the control group used Aspirin therapy.Comparing thrombolysis group and the control group of patients with acute cerebral infarction treatment after different treatments,and in the pre-treatment and post-treatment of patients with neurological deficit scores.Assess the safety of thrombolysis in patients,including symptoms of bleeding,revascularization occlusion.Result:After treatment,the treatment significantly improved compared with NIHSS scores(P<0.05),7 d thrombolytic therapy group than in the control group improved more significantly(P<0.01).Symptomatic hemorrhage,vascular occlusion of two groups,there were no significant difference(P>0.05).Conclusion:The incidence of acute cerebral infarction <3 h using rt-PA thrombolytic therapy has a good therapeutic effect,and better security.
Keywords：Recombinant Tissue-type Plasminogen ActivatorAcute cerebral infarctionIntravenous thrombolysisNeurological deficit
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 1-2,3 )